Effect of expression of gut-enriched kruppel-like factor on esophageal squamous cancer cells

Acta Biochimica et Biophysica Sinica

Volumn 35, Issue 1, 2003, Pages 55-58

  Wang, Nan ^a   Liu, Zhi Hua ^a   Ding, Fang ^a   Wang, Xiu Qin ^a   Wu, Min ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Cell adhesion; Cell proliferation; Esophageal cancer; Gut enriched Kruppel like factor; Transfection

Indexed keywords

KRUPPEL LIKE FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; CANCER GROWTH; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; DOWN REGULATION; ESOPHAGUS CANCER; GENETIC STRAIN; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; INTESTINE; METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL DIVISION; DNA, ANTISENSE; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EUKARYOTA;

EID: 0037220949     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem, 1996, 271(33): 20009-20017
2. Yet SF, McA' Nulty MM, Folta SC, Yen HW, Yoshizumi M, Hsieh CM, Layne MD et al. Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem, 1998, 273(2): 1026-1031
3. Garrett-Sinha LA, Eberspaecher H, Seldin MF, de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem, 1996, 271(49): 31384-31390
4. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR et al. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem, 2000, 275(24): 18391-18398
5. Jenkins TD, Opitz OG, Okano J, Rustgi AK. Transactivation of the human keratin 4 and Epstein-Barr virus ED-L2 promoters by gut-enriched Kruppel-like factor. J Biol Chem, 1998, 273(17): 1074710754
6. Brembeck FH, Rustgi AK. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Spl. J Biol Chem, 2000, 275(36): 28230-28239
7. Zhang W, Shields JM, Sogawa K, Fujii-Kuriyama Y, Yang VW. The gut-enriched Kruppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J Biol Chem, 1998, 273(28): 17917-17925
8. Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC. Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res, 2000, 28(15): 2969-2976
9. Geiman DE, Ton-That H, Johnson JM, Yang VW. Transactivation and growth suppression by the gut-enriched Kruppel-like factor (Kruppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res, 2000, 28(5): 1106-1113
10. Okano J, Opitz OG, Nakagawa H, Jenkins TD, Friedman SL, Rustgi AK. The Kruppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact. FEBS Lett, 2000, 473(1): 95-100
11. Segre JA, Bauer C, Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet, 1999, 22(4): 356-360
12. Ton-That H, Kaestner KH, Shields JM, Mahatanankoon CS, Yang VW. Expression of the gut-enriched Kruppel-like factor gene during development and intestinal tumorigenesis. FEBS Lett, 1997, 419(2-3): 239-243
13. Dang DT, Bachman KE, Mahatan CS, Dang LH, Giardiello FM, Yang VW. Decreased expression of the gut-enriched Kruppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett, 2000, 476(3): 203-207
14. Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE, Ruppert JM. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res, 2000, 60(22): 6488-6495
15. Dang DT, Mahatan CS, Dang LH, Agboola IA, Yang VW. Expression of the gut-enriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene, 2001, 20(35): 4884-4890.
16. Miller KA, Eklund EA, Peddinghaus ML, Cao Z, Fernandes N, Turk PW, Thimmapaya B et al. Kruppel-like factor 4 regulates laminin alpha 3A expression in mammary epithelial cells. J Biol Chem, 2001, 276(46): 42863-42868
17. Wang N, Liu ZH, Ding F, Wang XQ, Zhou CN, Wu M. Expression of Gut-enriched Kruppel-like Factor in esophageal squamous cancer. Prog Biochem Biophys, 2002, 29(1): 46-50
18. Shie JL, Chen ZY, O'Brien MJ, Pestell RG, Lee ME, Tseng CC. Role of gut-enriched Kruppel-like factor in colonic cell growth and differentiation. Am J Physiol Gastrointest Liver Physiol, 2000, 279(4): G806-G814
19. Kumchat P, Mauch C. Mechanisms of metastasis. Clin Exp Dermatol, 2000, 25(6): 482-489
20. Madhavan M, Srinivas P, Abraham E, Ahmed I, Mathew A, Vijayalekshmi NR, Balaram P. Cadherins as predictive markers of nodal metastasis in breast cancer. Mod Pathol, 2001, 14(5): 423-427
21. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res, 2001, 61(9): 3819-3825
22. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M et al. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Oncol Rep, 2001, 8(3): 485-489
23. Van Seuningen I, Perrais M, Pigny P, Porchet N, Aubert JP. Sequence of the 5′-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells. Biochem J, 2000, 348 Pt 3: 675-686
24. Hu N, Roth MJ, Emmert-Buck MR, Tang ZZ, Polymeropolous M, Wang QH, Goldstein AM et al. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin Cancer Res, 1999, 5(11): 3476-3482